Jean Kim Selected Research

Jean Kim Research Topics

Disease

7	Inflammation (Inflammations) 01/2023 - 01/2014
7	Rhinosinusitis 01/2021 - 12/2009
6	Neoplasms (Cancer) 01/2023 - 04/2011
5	Hypersensitivity (Allergy) 04/2024 - 05/2009
4	Asthma (Bronchial Asthma) 03/2024 - 01/2016
4	Nasal Polyps (Nasal Polyp) 01/2020 - 10/2004
3	Allergic Rhinitis 03/2024 - 01/2023
3	Polyps 01/2021 - 12/2009
3	Wounds and Injuries (Trauma) 06/2019 - 08/2009
3	Brain Injuries (Brain Injury) 08/2016 - 09/2002
2	COVID-19 03/2022 - 04/2021
2	Brain Neoplasms (Brain Tumor) 01/2021 - 10/2004
2	Pituitary Neoplasms (Pituitary Adenoma) 01/2020 - 02/2017
2	Acromegaly 01/2020 - 02/2017
2	Glaucoma 10/2018 - 01/2016
2	Sinusitis 10/2017 - 01/2014
2	Hyperplasia 02/2017 - 01/2014
2	Epilepsy (Aura) 08/2016 - 08/2009
2	Amyotrophic Lateral Sclerosis (Lou Gehrig's Disease) 11/2013 - 05/2009
1	Rhinitis 04/2024
1	Cross Infection (Nosocomial Infection) 11/2023
1	Perinatal Death 11/2023
1	Pulmonary Fibrosis (Fibrosing Alveolitis) 03/2022
1	Sialadenitis 01/2022
1	Carcinogenesis 11/2021
1	Cardiotoxicity 08/2021
1	Cardiomyopathies (Cardiomyopathy) 08/2021
1	Sepsis (Septicemia) 01/2021
1	Rare Diseases (Rare Disease) 01/2020
1	Atopic Dermatitis (Atopic Eczema) 01/2020
1	Growth Hormone-Secreting Pituitary Adenoma 01/2020
1	Schaaf-Yang syndrome 11/2019
1	Attention Deficit Disorder with Hyperactivity (Attention Deficit Hyperactivity Disorder) 11/2019
1	Treatment-Resistant Depressive Disorder 07/2019
1	Hallucinations (Hallucination) 06/2019
1	Melanoma (Melanoma, Malignant) 10/2017
1	Glucose Intolerance 02/2017
1	Macular Degeneration (Age-Related Maculopathy) 02/2017
1	Adenoma (Adenomas) 02/2017

Drug/Important Bio-Agent (IBA)

4	ZincIBA 08/2016 - 05/2009
3	Growth Hormone (Somatotropin)IBA 11/2021 - 02/2017
3	LigandsIBA 01/2021 - 01/2014
2	AllergensIBA 03/2024 - 03/2024
2	Epinephrine (Adrenaline)FDA LinkGeneric 03/2024 - 03/2024
2	Anti-Bacterial Agents (Antibiotics)IBA 01/2021 - 05/2009
2	polycaprolactoneIBA 10/2018 - 01/2016
2	Proteins (Proteins, Gene)FDA Link 02/2017 - 10/2004
2	Biomarkers (Surrogate Marker)IBA 01/2016 - 12/2009
2	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2014 - 12/2009
1	Environmental Pollutants (Pollutants, Environmental)IBA 04/2024
1	Carbon DioxideIBA 04/2024
1	Sialic Acid Binding Immunoglobulin-like LectinsIBA 01/2023
1	Iron-Dextran Complex (InFed)FDA Link 01/2023
1	Mineralocorticoid Receptor AntagonistsIBA 03/2022
1	AldosteroneIBA 03/2022
1	Spironolactone (Aldactone)FDA LinkGeneric 03/2022
1	CanrenoneIBA 03/2022
1	Antinuclear AntibodiesIBA 01/2022
1	Immunoglobulin G (IgG)IBA 01/2022
1	AntibodiesIBA 01/2022
1	Rheumatoid FactorIBA 01/2022
1	MicroRNAs (MicroRNA)IBA 11/2021
1	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 08/2021
1	N-Acetylneuraminic Acid (Sialic Acid)IBA 01/2021
1	Glycoproteins (Glycoprotein)IBA 01/2021
1	Protein Isoforms (Isoforms)IBA 01/2021
1	LectinsIBA 01/2021
1	Caspase 3 (Caspase-3)IBA 01/2021
1	Death Domain ReceptorsIBA 01/2021
1	Phosphotransferases (Kinase)IBA 01/2021
1	BIM23B065IBA 01/2020
1	dupilumabIBA 01/2020
1	Monoclonal AntibodiesIBA 01/2020
1	Insulin-Like Growth Factor I (IGF-1)IBA 01/2020
1	Dopamine Receptors (Dopamine Receptor)IBA 01/2020
1	Somatostatin (Somatotropin Release-Inhibiting Factor)IBA 01/2020
1	Therapeutic UsesIBA 01/2020
1	TOR Serine-Threonine KinasesIBA 11/2019
1	Sirolimus (Rapamycin)FDA Link 11/2019
1	4- (3,4- dichlorophenyl)- 1,2,3,4- tetrahydronaphthalen- 1- amineIBA 11/2019
1	EsketamineIBA 07/2019
1	Antidepressive Agents (Antidepressants)IBA 07/2019
1	Anesthetics (Anesthetic Agents)IBA 06/2019
1	Ketamine FDA LinkGeneric 06/2019
1	Analgesics (Analgesic Drugs)IBA 06/2019
1	Antiglaucoma AgentsIBA 10/2018
1	Ophthalmic Solutions (Eye Drops)IBA 10/2018
1	4- (1- (4- hydroxyphenyl)- 2- phenylbuten- 1- yl)phenoxy- n- butyric acidIBA 10/2017
1	IpilimumabIBA 10/2017
1	NivolumabIBA 10/2017
1	Immune Checkpoint InhibitorsIBA 10/2017
1	aryl hydrocarbon receptor-interacting proteinIBA 02/2017

Therapy/Procedure

7	Therapeutics 03/2024 - 05/2009
2	Injections 03/2024 - 03/2024
2	Immunotherapy 03/2024 - 03/2024
1	Neonatal Intensive Care 11/2023
1	Drug Therapy (Chemotherapy) 08/2021
1	Personal Protective Equipment 04/2021
1	Critical Care (Surgical Intensive Care) 01/2021
1	Duration of Therapy 01/2020